Search clinical trials for: Oral Vancomycin

Total 17828 results

Clinical Research Centre, Malaysia

Not yet recruiting

Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia (EVOS)

Staphylococcus Aureus Bacteremia

Malaysia
University of Minnesota

Recruiting

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

Primary Sclerosing Cholangitis

United States
South Australian Health and Medical Research Institute
University of Sydney; Telethon Kids Institute; Flinders University; Royal Adelaide... and other collaborators

Recruiting

Antibiotics and Vaccine Immune Responses Study (AVIRS)

Vaccine Response Impaired

Australia
University of Milano Bicocca
Genetic s.p.a.

Recruiting

Vancomycin in Primary Sclerosing Cholangitis in Italy (VanC-IT)

Primary Sclerosing Cholangitis | IBD | Liver and Intrahepatic Bile Duct Disorder

Italy
Intralytix, Inc.

Recruiting

Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

Vancomycin-Resistant Enterococcal Colonization

United States
Leiden University Medical Center

Recruiting

Clostridioides Difficile Colonisation (CloDiCo)

Clostridioides Difficile Infection

Netherlands
Michael Dill
University of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaborators

Not yet recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)

Immunotherapy

Germany
University Hospital Birmingham NHS Foundation Trust

Recruiting

A Systems Biology Approach for Identification of Host and Microbial Mechanisms and Druggable Targets for the Treatment of PSC-IBD (PSC-Vanc)

Inflammatory Bowel Diseases | Primary Sclerosing Cholangitis

United Kingdom
Vedanta Biosciences, Inc.

Recruiting

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

Ulcerative Colitis | Colitis, Ulcerative

United States, Netherlands, Lithuania, Bulgaria, Hungary, Ukraine, Czechia, Poland, United Kingdom
Julia Orígüen
Instituto de Salud Carlos III

Recruiting

Oral Vancomycin vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection (PREVAN)

Clostridioides Difficile Infection

Spain
Benoit Guery

Recruiting

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence (FENDER)

Clostridioides Difficile Infection

Switzerland
Assistance Publique - Hôpitaux de Paris
GIRCI Ile de France

Not yet recruiting

Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (VANCALLO)

Stem Cell Transplant Complications | Clostridium Difficile Infections
University of Melbourne
King's College London; Radboud University Medical Center; Rambam Health Care... and other collaborators

Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial (SNAP)

Staphylococcus Aureus Bacteremia

Australia, Canada, Netherlands, New Zealand, United Kingdom, Singapore, South Africa, Israel
MEDSI Clinical Hospital 1, ICU

Recruiting

Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria

Respiratory Tract Infections | Pneumonia | Sepsis | Critical Illness | Respiratory Distress Syndrome | Pneumonia, Ventilator-Associated | Bloodstream Infection

Russian Federation
Hamilton Health Sciences Corporation

Recruiting

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients (Decency-RCT)

Clostridium Difficile Diarrhea | Clostridium Difficile Colonization

Canada
Radboud University Medical Center

Not yet recruiting

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery (REMEDI)

Coronary Artery Disease | Systemic Inflammatory Response Syndrome | Extracorporeal Circulation; Complications | Postoperative Shock

Netherlands
University Hospital, Tours

Recruiting

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Infective Endocarditis

France
University Hospital, Tours

Recruiting

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus

Infective Endocarditis

France
Sacramento Pediatric Gastroenterology

Recruiting

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Primary Sclerosing Cholangitis | Biliary Atresia

United States
Acurx Pharmaceuticals Inc.

Completed

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Clostridium Difficile Infection

United States
Patricia Bloom
American College of Gastroenterology; American Association for the Study of... and other collaborators

Completed

VE303 for Treatment of Hepatic Encephalopathy (HE)

Hepatic Encephalopathy | Cirrhosis

United States
Crestone, Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Clostridioides Difficile Infection

United States, Canada
West Virginia University

Enrolling by invitation

Comparing Oral Versus Parenteral Antimicrobial Therapy (COPAT)

Skin and Soft Tissue Infection | Gastrointestinal Infection | Pulmonary Infection | Bone and Joint Infection | Endovascular Infection | Genitourinary Infection

United States
Vinay Badhwar

Enrolling by invitation

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) (OPTIMAL)

Endocarditis

United States
University of Nevada, Reno
Renown Regional Medical Center

Completed

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Clostridium Difficile Infection

United States
Imperial College London
Hammersmith Hospitals NHS Trust

Completed

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

Staphylococcal Infections | Gram-positive Bacterial Infections

United Kingdom
Daniel Benjamin
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)

Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions

United States, Canada, United Kingdom, Israel, Singapore
Vedanta Biosciences, Inc.
Bristol-Myers Squibb

Completed

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (ConsortiumIO)

Melanoma | Gastric Cancer | Colorectal Cancer | Metastatic Cancer | Gastroesophageal Junction Adenocarcinoma

United States
University of Wisconsin, Madison
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

Clostridium Difficile Infection Recurrence

United States
University of Wisconsin, Madison
Mayo Clinic; Medical College of Wisconsin; Agency for Healthcare Research and... and other collaborators

Completed

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | CDI | C.Difficile Diarrhea | C. Diff Colitis | C.Difficile Colitis

United States
National Cancer Institute (NCI)

Completed

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Metastatic Colorectal Cancer | Hepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Pancreatic Cancer | Liver Metastasis

United States
University of South Florida

Terminated

Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

Clostridium Difficile Infection | Clostridium Difficile Infection Recurrence

United States
Leiden University Medical Center
Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Withdrawn

Bezlotoxumab Versus FMT for Multiple Recurrent CDI (BSTEP)

Clostridium Infections | Enterocolitis, Pseudomembranous | Clostridioides Difficile

Netherlands
National Cancer Institute (NCI)

Completed

Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

Locally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine Tumor

United States, Canada
University of Kansas Medical Center
Merck Sharp & Dohme LLC

Completed

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection (BEZLO)

Clostridium Difficile Infection Recurrence

United States
University Hospital, Essen

Completed

Registration of Idarucizumab for Patients With IntraCranial Hemorrhage (RIC-ICH)

Intracranial Hemorrhage

Germany
Boston Medical Center

Terminated

Fecal Microbiota Transplant for Primary CDI

Clostridium Difficile Infection

United States
Medical College of Wisconsin

Completed

Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

Clostridium Difficile Infection

United States
Washington University School of Medicine

Completed

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Diarrhea | Clostridium Difficile Infection

United States
Rochester General Hospital

Terminated

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

Clostridium Difficile Infection

United States
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Moderate Clostridium Difficile Infection

United States, Canada
Medical College of Wisconsin

Completed

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Hematologic Diseases | Clostridium Difficile Infection | Oncologic Disorders | Bone Marrow Transplant

United States
National Institute of Diabetes and Digestive and...

Completed

Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans

Obesity

United States
Heinrich-Heine University, Duesseldorf
German Research Foundation

Completed

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options (SABATO)

Staphylococcus Aureus Infection

France, Germany, Netherlands, Spain, United Kingdom
Astellas Pharma Europe B.V.
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (SUNSHINE)

Clostridium Difficile-associated Diarrhea (CDAD)

United States, Belgium, Italy, Canada, France, Germany, Hungary, Poland, Romania, Spain
National Cancer Institute (NCI)

Withdrawn

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

United States
Vedanta Biosciences, Inc.

Completed

First-in-human Study of VE303 in Healthy Adult Volunteers

Healthy Volunteers

United States
Creighton University

Withdrawn

Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI

CDI

United States
Arizona State University
University of Minnesota; University of Arizona; Northern Arizona University

Completed

Beneficial Bacteria Treatment for Autism (BBT)

Autism Spectrum Disorders | Gastrointestinal Problems

Search clinical trials for: Oral Vancomycin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations